Davinthra Thillainathan

Stock Analyst at Goldman Sachs

(1.05)
# 3,617
Out of 4,356 analysts
34
Total ratings
33.3%
Success rate
-3.3%
Average return

Stocks Rated by Davinthra Thillainathan

Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $27.36
Upside: +16.23%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Maintained: Buy
Price Target: $51.53$53.09
Current: $37.29
Upside: +42.37%
ResMed Inc.
Feb 2, 2026
Maintained: Buy
Price Target: $49.30$53.20
Current: $26.49
Upside: +100.83%
Integral Diagnostics Limited
Dec 18, 2025
Initiated Coverage: Sell
Price Target: $2.10
Current: $2.17
Upside: -3.23%
CSL Limited
Oct 29, 2025
Maintained: Buy
Price Target: $304.60$212.10
Current: $94.92
Upside: +123.45%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $6.80
Current: $3.22
Upside: +111.32%
Ramsay Health Care Limited
Sep 11, 2025
Maintained: Hold
Price Target: n/a
Current: $36.13
Upside: -
Healius Limited
Aug 12, 2025
Maintained: Sell
Price Target: $1.20$0.80
Current: $0.34
Upside: +135.29%
Cochlear Limited
Jun 14, 2025
Maintained: Hold
Price Target: n/a
Current: $100.88
Upside: -
Sonic Healthcare Limited
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $18.96
Upside: n/a
Initiated Coverage: Hold
Price Target: $3.30
Current: $2.03
Upside: n/a